Toll Free: 1-888-928-9744

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 302 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016" provides an overview of Gastrointestinal Stromal Tumor (GIST) clinical trials scenario. This report provides top line data relating to the clinical trials on Gastrointestinal Stromal Tumor (GIST). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Gastrointestinal Stromal Tumor (GIST) 31 May 24, 2016: Arog Pharmaceuticals Presents Crenolanib Clinical Data at the 2016 American Society of Clinical Oncology Annual Meeting 31 Apr 20, 2016: Kolltan Pharmaceuticals Announces Presentations of Anti-KIT Antibody Preclinical Data at the 2016 American Association for Cancer Research Annual Meeting 31 Clinical Trial Profile Snapshots 33 Appendix 299 Abbreviations 299 Definitions 299 Research Methodology 300 Secondary Research 300 About GlobalData 301 Contact Us 301 Disclaimer 301 Source 302
List of Tables
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 300

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify